TM7SF3
Transmembrane 7 superfamily member 3
Also known as: TM7S3_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9NS93
- Gene
- TM7SF3
- Ensembl
- ENSG00000064115
- Chromosome
- 12
- Canonical length
- 570 aa
- Protein class
- Predicted intracellular proteins, Predicted membrane proteins
- Subcellular location
- Nucleoplasm,Cytosol
OverviewNCBI Gene
Involved in cellular response to unfolded protein; negative regulation of programmed cell death; and positive regulation of insulin secretion. Located in plasma membrane. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
570 residues, UniProt reviewed canonical sequence.
>Q9NS93|TM7SF3
1 MGFLQLLVVA VLASEHRVAG AAEVFGNSSE GLIEFSVGKF RYFELNRPFP EEAILHDISS
61 NVTFLIFQIH SQYQNTTVSF SPTLLSNSSE TGTASGLVFI LRPEQSTCTW YLGTSGIQPV
121 QNMAILLSYS ERDPVPGGCN LEFDLDIDPN IYLEYNFFET TIKFAPANLG YARGVDPPPC
181 DAGTDQDSRW RLQYDVYQYF LPENDLTEEM LLKHLQRMVS VPQVKASALK VVTLTANDKT
241 SVSFSSLPGQ GVIYNVIVWD PFLNTSAAYI PAHTYACSFE AGEGSCASLG RVSSKVFFTL
301 FALLGFFICF FGHRFWKTEL FFIGFIIMGF FFYILITRLT PIKYDVNLIL TAVTGSVGGM
361 FLVAVWWRFG ILSICMLCVG LVLGFLISSV TFFTPLGNLK IFHDDGVFWV TFSCIAILIP
421 VVFMGCLRIL NILTCGVIGS YSVVLAIDSY WSTSLSYITL NVLKRALNKD FHRAFTNVPF
481 QTNDFIILAV WGMLAVSGIT LQIRRERGRP FFPPHPYKLW KQERERRVTN ILDPSYHIPP
541 LRERLYGRLT QIKGLFQKEQ PAGERTPLLLLocalizationUniProt · AlphaFold · HPA
Whether an antibody against TM7SF3 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 7
- Mean surface accessibility (rSASA)
- 0.29
- Highest tissue expression
- 239 nTPM
Expression across tissuesHPA
Tissue
- kidney: 239 nTPM
- liver: 129 nTPM
- pancreas: 111 nTPM
- thymus: 94 nTPM
- rectum: 65 nTPM
- bone marrow: 62 nTPM
Single-cell type
- proximal tubule cells: 349 nCPM
- melanocytes: 270 nCPM
- cholangiocytes: 264 nCPM
- late spermatids: 253 nCPM
- megakaryocyte progenitors: 209 nCPM
- neutrophil progenitors: 203 nCPM
Immune cell
- eosinophil: 19 nTPM
- T-reg: 14 nTPM
- NK-cell: 14 nTPM
- naive B-cell: 13 nTPM
- myeloid DC: 12 nTPM
- naive CD4 T-cell: 11 nTPM
Brain region
- choroid plexus: 85 nTPM
- white matter: 74 nTPM
- thalamus: 68 nTPM
- cerebral cortex: 67 nTPM
- spinal cord: 67 nTPM
- medulla oblongata: 66 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.84
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.89
- DepMap mean gene effect
- -0.01
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 7% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cellular response to unfolded protein
- negative regulation of programmed cell death
- positive regulation of insulin secretion
Cellular components
Protein domainsUniProt · Pfam · InterPro
- TM7S3/TM198-like domain
- TM7S3/TM198-like domain
- Transmembrane 7 superfamily member 3
- TM7SF3-like, N-terminal immunoglobulin-like domain
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads TM7SF3 as an antibody target. Whether an autoantibody or antibody against TM7SF3 could matter depends on whether native TM7SF3 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
TM7SF3 is annotated at the cell surface, where native TM7SF3 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label TM7SF3 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...